These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19453946)

  • 21. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
    Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
    Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A specific requirement of Arc/Arg3.1 for visual experience-induced homeostatic synaptic plasticity in mouse primary visual cortex.
    Gao M; Sossa K; Song L; Errington L; Cummings L; Hwang H; Kuhl D; Worley P; Lee HK
    J Neurosci; 2010 May; 30(21):7168-78. PubMed ID: 20505084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down Syndrome correlate with structural plasticity markers.
    Villarroya O; Ballestín R; López-Hidalgo R; Mulet M; Blasco-Ibáñez JM; Crespo C; Nacher J; Gilabert-Juan J; Varea E
    Histol Histopathol; 2018 Jan; 33(1):101-115. PubMed ID: 28374408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice.
    Kurt MA; Davies DC; Kidd M; Dierssen M; Flórez J
    Brain Res; 2000 Mar; 858(1):191-7. PubMed ID: 10700614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome.
    Wang X; Yang Q; Zhou X; Keene CD; Ryazanov AG; Ma T
    Alzheimers Dement; 2024 Aug; 20(8):5357-5374. PubMed ID: 38934363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome.
    Dierssen M; Vallina IF; Baamonde C; García-Calatayud S; Lumbreras MA; Flórez J
    Brain Res; 1997 Feb; 749(2):238-44. PubMed ID: 9138724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
    Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
    Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation.
    Sahir N; Brenneman DE; Hill JM
    J Mol Neurosci; 2006; 30(3):329-40. PubMed ID: 17401158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome.
    Thomazeau A; Lassalle O; Manzoni OJ
    Front Neurosci; 2023; 17():1171797. PubMed ID: 37841687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.
    Belichenko NP; Belichenko PV; Kleschevnikov AM; Salehi A; Reeves RH; Mobley WC
    J Neurosci; 2009 May; 29(18):5938-48. PubMed ID: 19420260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.
    Harashima C; Jacobowitz DM; Witta J; Borke RC; Best TK; Siarey RJ; Galdzicki Z
    J Comp Neurol; 2006 Feb; 494(5):815-33. PubMed ID: 16374808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.
    Almeida CG; Tampellini D; Takahashi RH; Greengard P; Lin MT; Snyder EM; Gouras GK
    Neurobiol Dis; 2005 Nov; 20(2):187-98. PubMed ID: 16242627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome.
    Brault V; Nguyen TL; Flores-Gutiérrez J; Iacono G; Birling MC; Lalanne V; Meziane H; Manousopoulou A; Pavlovic G; Lindner L; Selloum M; Sorg T; Yu E; Garbis SD; Hérault Y
    PLoS Genet; 2021 Sep; 17(9):e1009777. PubMed ID: 34587162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models.
    Liu H; Caballero-Florán RN; Hergenreder T; Yang T; Hull JM; Pan G; Li R; Veling MW; Isom LL; Kwan KY; Huang ZJ; Fuerst PG; Jenkins PM; Ye B
    PLoS Biol; 2023 Apr; 21(4):e3002078. PubMed ID: 37079499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of Down syndrome.
    Popov VI; Kleschevnikov AM; Klimenko OA; Stewart MG; Belichenko PV
    J Comp Neurol; 2011 May; 519(7):1338-54. PubMed ID: 21452200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer's disease.
    Lauterborn JC; Scaduto P; Cox CD; Schulmann A; Lynch G; Gall CM; Keene CD; Limon A
    Nat Commun; 2021 May; 12(1):2603. PubMed ID: 33972518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome.
    Siarey RJ; Villar AJ; Epstein CJ; Galdzicki Z
    Neuropharmacology; 2005 Jul; 49(1):122-8. PubMed ID: 15992587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome.
    Morice E; Farley S; Poirier R; Dallerac G; Chagneau C; Pannetier S; Hanauer A; Davis S; Vaillend C; Laroche S
    Neurobiol Dis; 2013 Oct; 58():156-68. PubMed ID: 23742761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of trisomic proteins in Down syndrome model systems.
    Spellman C; Ahmed MM; Dubach D; Gardiner KJ
    Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.